Trimethoprim-sulfamethoxazole treatment of cholangitis complicating congenital hepatic fibrosis.
D000293:Adolescent; D000667:Ampicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002761:Cholangitis / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D004338:Drug Combinations / Q000627:therapeutic use; D004754:Enterobacter; D004756:Enterobacteriaceae Infections / Q000188:drug therapy; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D008107:Liver Diseases / Q000150:complications / Q000151:congenital* / Q000473:pathology; D008297:Male; D012008:Recurrence; D012480:Salmonella Infections / Q000188:drug therapy; D012477:Salmonella enteritidis; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D014295:Trimethoprim / Q000627:therapeutic use*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D005839:Gentamicins; D000667:Ampicillin; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D014295:Trimethoprim; D013420:Sulfamethoxazole